Compounds pharmaceutical compositions and methods for...

Details Compounds pharmaceutical compositions and methods for... Compounds pharmaceutical compositions and methods for...

2002-01-16

2008-10-14

Russel, Jeffrey E (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S011400, C514S013800, C514S014800, C514S015800, C530S300000, C530S319000, C530S326000, C530S327000, C530S345000

Reexamination Certificate

active

07435716

ABSTRACT:
Novel conjugates of bacterial outer membrane binding peptides, preferably having bacterial sensitization activity, and immune cells chemotactic peptides, and pharmaceutical compositions containing same useful in the treatment of bacteremia and/or septicemia following infection by gram negative bacteria administered alone or in combination with conventional antibiotics.

REFERENCES:
patent: 4427660 (1984-01-01), Schiffman et al.
patent: 5484885 (1996-01-01), Pereira et al.
patent: 5780429 (1998-07-01), Wainwright
patent: 5925659 (1999-07-01), Patchett et al.
patent: 6733997 (2004-05-01), Ding et al.
patent: 6861053 (2005-03-01), Lin et al.
patent: 2001/0026810 (2001-10-01), McGhee et al.
patent: 2002/0049205 (2002-04-01), Li et al.
Bycroft et al. Antibacterial and Immunostimulatory Properties of Chemotactic . . . Antimicrobial Agents And Chemotherapy. Sep. 1989, vol. 33, No. 9, pp. 1516-1521.
Appelmelk et al. Analytical Biochemistry. Dec. 1992, vol. 207, No. 2, pp. 311-316.
Amoscato et al. Peptides. May-Jun. 1984. vol. 5, No. 4, pp. 489-494.
Tsubery et al. Biochemistry. Oct. 2000, vol. 39, No. 39, pp. 11837-11844.
Tsubery et al. Journal Of Medicinal Chemistry. Aug. 2000, vol. 43, No. 16, pp. 3085-3092.
Tsubery et al. Advances In Experimental Medicine And Biology. 2000, vol. 479, pp. 219-222.
Ofek et al. Antimicrobial Agents And Chemotherapy. Feb. 1994, vol. 38, No. 2, pp. 374-377.
Tsubery et al. Peptides. Oct. 2001, vol. 22, No. 10, pp. 1675-1681.
Appelmelk et al. “Polymyxin B-Horseradish Peroxidase Conjugates as Tools in Endotoxin Research”. Analytical Biochemistry, 207(2): 311-316, 1992.
Amoscato et al. “Synthesis and Biological Activity of [L-3,4-Dehydroproline3]-Tuftsin.” Peptides, 5(3): 489-494, 1984.
Tsubery et al. “The Functional Association of Polymyxin B With Bacterial Lipopolysaccharide Is Stereospecific: Studies on Polymyxin B Nonapeptide”, Biochemistry, 39(39): 11837-11844, 2000.
Tsubery et al. “Structure-Function Studies of Polymyxin B Nonapeptide: Implications to Sensitization of Gram-Negative Bacteria”, Journal of Medicinal Chemistry, 43(16): 3085-3092, 2000.
Tsubery et al. “Structure Activity Relationship Study of Polymyxin B Nonapeptide”, Advances in Experimental Medicine and Biology, 479: 219-222, 2000.
Tsubery et al. “N-Terminal Modifications of Polymyxin B Nonapeptide and Their Effect on Antibacterial Activity”, Peptides, 22(10): 1675-1681, 2001.
Athamna et al. “Enzyme-Linked Immunosorbent Assay for Quantitation of Attachment and Ingestion Stages of Bacterial Phagocytosis”, Journal of Clinical Microbiology, 26(1): 62-66, 1988.
Athamna et al. “Lectinophagocytosis of Encapsulated Klebsiella Pneumoniae Mediated by Surface Lectins of Guinea Pig Alveolar Macrophages and Human Monocyte-Derived Macrophages”, Infection and Immunity, 59(5): 1673-1682, 1991.
Becker “Some Interrelations of Neutrophil Chemotaxis, Lysosomal Enzyme Secretion, and Phagocytosis as Revealed by Synthetic Peptides”, American Journal of Pathology, 85: 385-394, 1976.
Bryan “Mechanisms of Resistance to Antibacterial Agents”, In: ‘Bacterial Resistance and Susceptibility to Chemotherapeutic Agents’, Cambridge University Press, Chap.3: 69-80, 1982.
Chihara et al. “Chemical Synthesis, Isolation and Characterization of α-N-Fattyacyl Colistin Nonapeptide With Special Reference to the Correlation Between Antimicrobial Activity and Carbon Number of Fattyacyl Moiety”, Agricultural Biology and Chemistry, 38(3): 521-529, 1974.
Chihara et al. “Enzymatic Degradation of Colistin Isolation and Identification of α,γ-Diaminobutyric Acid and Colistin Nonapeptide”, Agricultural Biology and Chemistry, 37(11): 2455-2463, 1973.
Chin et al. “Resistance to Antibiotics”, Science, 264: 359-393, 1994.
Danner et al. “Purification, Toxicity, and Antiendotoxin Activity of Polymyxin B Nonapeptide”, Anitmicrobial Agents and Chemotherapy, 33(9): 1428-1434, 1989.
Duwe et al. “In Vitro Cytotoxicity and Antibiotic Activity of Polymyxin B Nonapeptide”, Antimicrobial Agents and Chemotherapy, 30(2): 340-341, 1986.
Freer et al. “Further Studies on the Structural Requirements for Synthetic Peptide Chemoattractants”, Biochemistry, 19: 2404-2410, 1980.
Freer et al. “Formyl Peptide Chemoattractants: Model of the Receptor on Rabbit Neutrophils”, Biochemistry, 21: 257-263, 1982.
Kitamura-Matsunaga et al. “Enzymic Preparation of Colistin Fragments and Their Biological Activity”, Peptide Chemistry, 22: 333-338, 1984. Abstract.
Lam et al. “Membrane-Disorganizing Property of Polymyxin B Nonapeptide”, Journal of Antimicrobial Chemotherapy, 18: 9-15, 1986.
Metcalf et al. “Functions Related to Microbicidal Activity”, Laboratory Manual of Neutrophil Function, Chap.5: 87-90, 1986.
Morrison et al. “Binding of Polymyxin B to the Lipid A Portion of Bacterial Lipopolysaccharides”, Immunochemistry, 13: 813-818, 1976.
Niedel et al. “Formyl Peptide Chemotactic Receptors of Leukocytes and Macrophages”, Current Topics in Cellular Regulation, 17: 137-169, 1980.
Ofek et al. “Antibacterial Synergism of Polymyxin B Nonapeptide and Hydrophobic Antibiotics in Experimental Gram-Negative Infections in Mice”, Antimicrobial Agents and Chemotherapy, 38(2): 374-377, 1994.
Ofek et al. “Nonopsonic Phagocytosis of Microorganisms”, Annual Reviews in Microbiology, 49: 239-276, 1995.
Rustici et al. “Molecular Mapping and Detoxification of the Lipid A Binding Site by Synthetic Peptides”, Science, 259: 361-365, 1993.
Schiffmann et al. “N-Formylmethionyl Peptides as Chemoattractants for Leucocytes”, Proc. Natl. Acad. Sci. USA, 72(3): 1059-1062, 1975.
Søgaard “The Pharmacodynamics of Polymyxin Antibiotics With special Reference to Drug Restistance Liability”, J. Vet. Pharmacol. Therapy, 5: 219-231, 1982.
Vaara “Agents That Increse the Permeability of the Outer Membrane”, Microbiological Reviews, 56(3): 395-411, 1992.
Vaara et al. “Binding of Polymyxin B Nonapeptide to Gram-Negative Bacteria”, Antimicrobial Agents and Chemotherapy, 27(4): 548-554, 1985.
Vaara et al. “Polycations Sensitize Enteric Bacteria to Antibiotics”, Antimicrobial Agents and Chemotherapy, 24(1): 107-113, 1983.
Voitenko et al. “Relationship Between Structure and Histamine Releasing Action of Polymyxin B and Its Analogues”, Agents and Actions, 30(½): 153-156, 1990.
Young “Gram-Negative Sepsis”, In: ‘Principles and Practice of Infectious Diseases’, Wiley & Sons, Section E, Chap.54: 452-475, 1985.
Chihara et al. “Chemical Synthesis, Isolation and Characterization of ?-N-Fattyacyl Colistin Nonapeptide With Special Reference to the Correlation Between Antimicrobial Activity and Carbon Number of Fattyacyl Moiety”, Agricultural Biology and Chemistry, 38(3): 521-529, 1974.
Chihara et al. “Enzymatic Degradation of Colistin Isolation and Identification of ?,?-Diaminobutyric Acid and Colistin Nonapeptide”, Agricultural Biology and Chemistry, 37(11): 2455-2463, 1973.
EP/Summons to Attend Oral Proceedings of EP Application 02715695.6 dated Feb. 8, 2008.
EP Brief Communication of Apr. 22, 2008 on Oral Proceedings of May 7, 2008.
Obrist et al. “Conjugation Behaviour of Different Monoclonal Antibodies to F-Methionyl-Leucyl-Phenylalanine”, International Journal of Immunopharmacology, 8(6): 629-632, 1986.
Rose et al. “Targeting Lipopolysaccharides by the Nontoxic Polymyxin B Nonapeptide Sensitizes ResistantEscherichia colito the Bactericidal Effect of Human Neutrophils”, The Journal of Infectious Diseases, 182: 191-199, 2000.
Tsubery et al. “Neopeptide Antibiotics That Function as Opsonins and Membrane-Permeabilizing Agents for Gram-Negative Bacteria”, Antimicr

Affiliated with

Also associated with

Rating

Compounds pharmaceutical compositions and methods for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds pharmaceutical compositions and methods for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds pharmaceutical compositions and methods for... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3999620